1 Growth Stock Down 27% to Buy Right Now

1 Growth Stock Down 27% to Buy Right Now


  • A delay of Rocket Labs’ Neutron’s launch sparked a 27% selloff, but shares have partially recovered.

  • The third quarter saw record revenue of $155 million, 17 Electron contracts, and a $1 billion backlog.

  • Analyst consensus rates it a moderate buy with a high target price, implying solid upside for investors.

  • These 10 stocks could mint the next wave of millionaires ›

Rocket Lab (NASDAQ: RKLB) had one of the most promising bull runs in 2025 — until one announcement brought the stock crashing over 27% in a month.

Some investors think of Rocket Lab as “SpaceX-lite,” noting that it operates in the same ring (reusable rockets) but in different weight classes (SpaceX mostly does medium- to heavy-lift and mega-constellation launches, while Rocket Lab focuses on small-satellite launches).

Rocket Lab’s Neutron was set to change all that. The medium-lift rocket increases its payload mass to 13,000 kg for low Earth orbit (LEO), which makes it a viable alternative to SpaceX’s medium-lift clients that don’t necessarily need a full Falcon 9 experience.

A rocket in space.
Image source: Getty Images.

However, according to its third-quarter financials released on Nov. 10, Rocket Lab “updated” its Neutron launch schedule from the end of 2025 to the first quarter of 2026.

And I get it — delays like this can spook investors and shatter market confidence. However, for those silver-lining types, this downtrend actually presents a great entry opportunity for this growth stock. Here’s why.

First, let’s delve into the third-quarter financials. Rocket Lab secured 17 Electron launch contracts in just the third quarter, with the Electron being its small-lift rocket. For reference, Rocket Lab had only 12 Electron launches across the entire nine-month period of 2024, right around this time last year. That shows massive scaling.

The company also reported impressive 48% top-line growth to a record $155 million. Gross margin (on a GAAP basis) also improved to 37%. It did report higher revenue and R&D costs for this quarter, though it was mostly offset by certain tax benefits. As a result, net losses were lower at $0.03 per share.

CEO Sir Peter Beck also stated that the company has a “$1.05 billion backlog,” which indicates strong demand and a solid foundation for future revenue growth. On top of that, it announced a new federal defense contract for its Neutron rocket and Archimedes reusable engine development with the U.S. Air Force’s Research Laboratory.

Together with other previous agreements with the U.S. and U.K., this proves Rocket Lab has an increasingly viable on-ramp to bigger defense contracts.


finance.yahoo.com
#Growth #Stock #Buy

Share: X · Facebook · LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *